Baiju dhea 15.11.12

44
Page 1 DHEA in Oocyte Yield and DHEA in Oocyte Yield and Quality Quality BAIJU P A BAIJU P A NCARE IVF CENTRE NCARE IVF CENTRE PARAPPANANGADI, MALAPPURAM PARAPPANANGADI, MALAPPURAM

description

DHEA

Transcript of Baiju dhea 15.11.12

Page 1: Baiju dhea 15.11.12

Page 1

DHEA in Oocyte Yield and QualityDHEA in Oocyte Yield and Quality

BAIJU P ABAIJU P ANCARE IVF CENTRENCARE IVF CENTREPARAPPANANGADI, PARAPPANANGADI,

MALAPPURAMMALAPPURAM

Page 2: Baiju dhea 15.11.12

Page 2

Dr Neeko

Baiju

Page 3: Baiju dhea 15.11.12

Page 3

Page 4: Baiju dhea 15.11.12

Page 4

DHEA - Hype or Hope…???DHEA - Hype or Hope…???

Follicular Dynamics

Androgen in Follicular Dynamics

What is DHEA?

Role of DHEA in Failing Ovaries

Side effects of DHEA

Literature Search

Other Adjuvants

Page 5: Baiju dhea 15.11.12

Page 5

8 million

4 million

4,00,000

25,000

1000

300-400 cycles in reproductive age 1000 follicles recruited/cycle

Page 6: Baiju dhea 15.11.12

Page 6

Page 7: Baiju dhea 15.11.12

Page 7

Page 8: Baiju dhea 15.11.12

Page 8

AMH as a predictive marker in ART: Lamarca et al: HR Update; Vol 16, No: 2, Pages 113-130; 2010

Page 9: Baiju dhea 15.11.12

Page 9

Biological Plausibility of Biological Plausibility of Androgens in Androgens in

Folliculogenesis Folliculogenesis

Page 10: Baiju dhea 15.11.12

Page 10

Page 11: Baiju dhea 15.11.12

Page 11

Page 12: Baiju dhea 15.11.12

Page 12

Page 13: Baiju dhea 15.11.12

Page 13

Greatest Challenge in Greatest Challenge in ART…!!!ART…!!!9-25% 9-25%

Page 14: Baiju dhea 15.11.12

Page 14

Poor Responders

Current trends of marriage and pregnancy

Maria et al. Ann. N.Y. Acad. Sci. 2008; 1127: 27–30, Gianaroli et al. Hum Reprod. 2010;25: 2374–2386, Schoolcraft et al. Fertil Steril. 2011 Sep; 96(3):638-40.

Page 15: Baiju dhea 15.11.12

Page 15

Page 16: Baiju dhea 15.11.12

Page 16

Page 17: Baiju dhea 15.11.12

Page 17

Mild therapeutically well tolerated male hormone (85% in Adrenals & 15% in Ovaries)

Page 18: Baiju dhea 15.11.12

Page 18

Page 19: Baiju dhea 15.11.12

Page 19

Wild Yam Extract Wild Yam Extract

Page 20: Baiju dhea 15.11.12

Page 20

• Adrenal Insufficiency• SLE• Depression• Obesity

• Alzheimer’s Disease• Cervical Cancer• Infertility• Sexual Dysfunction• Chronic Fatigue

Syndrome• HIV/AIDS• RA• Psoriasis• Schizophrenia

Page 21: Baiju dhea 15.11.12

Page 21

•Recruitment of Dormant Follicles from Pool•Reduction of Apoptosis

•Direct Effect on Granulosa Cells•Improved Mitochondrial Function

Page 22: Baiju dhea 15.11.12

Page 22

New Concept in Oocyte AgingNew Concept in Oocyte Aging(Barad & Gliecher – Submitted for Publication 2012)

Recruitment of more “young “ – chromosomally competent oocytes by altering internal follicular milieu

Quality of oocytes Quantity of oocytesQuality of embryos

Decreased Miscarriage RatesImproved LBR

Page 23: Baiju dhea 15.11.12

Page 23

Age

Low Androgen Levels

Poor Meiotic Competence

Poor Quality Ooocytes

DHEA

IGF-1

Normal oocyte maturation

Reduction of ApoptosisActivation of GC & TC Function

Improved Mitocondrial FunctionImproved Steroidal Milieu

Recruitment of young oocytes

Page 24: Baiju dhea 15.11.12

Page 24

Page 25: Baiju dhea 15.11.12

Page 25

Most common side effects…!!!

More energized… Improved sexual drive…

Page 26: Baiju dhea 15.11.12

Page 26

Page 27: Baiju dhea 15.11.12

Page 27

Since first-trimester placenta produces DHEA , maternal DHEA exposure at Since first-trimester placenta produces DHEA , maternal DHEA exposure at moderate dosages in very early pregnancy should not constitute significant riskmoderate dosages in very early pregnancy should not constitute significant risk

(Loganath, A., Peh, K.L., Wong, P.C., 2002. Evidence for the biosynthesis of DHEA from cholesterol by first trimester human placental tissue: source of androgens.

Horm. Metab. Res. 34, 116–120.)

Page 28: Baiju dhea 15.11.12

Page 28

Page 29: Baiju dhea 15.11.12

Page 29

Page 30: Baiju dhea 15.11.12

Page 30

Page 31: Baiju dhea 15.11.12

Page 31

Page 32: Baiju dhea 15.11.12

Page 32

Page 33: Baiju dhea 15.11.12

Page 33

Page 34: Baiju dhea 15.11.12

Page 34

Page 35: Baiju dhea 15.11.12

Page 35

Page 36: Baiju dhea 15.11.12

Page 36

1. Is there a scientifically explainable basis?

2. Does it harm?3. Do we have robust evidence in

other alternatives?4. Does it cause financial burden?5. What are deleterious effects of 3-

4 months delay in Rx ?

Questions to be

asked???

Page 37: Baiju dhea 15.11.12

Page 37

Page 38: Baiju dhea 15.11.12

Page 38

Other Adjuvants

Page 39: Baiju dhea 15.11.12

Page 39

Page 40: Baiju dhea 15.11.12

Page 40

Pre-Ovulatory Pre-Ovulatory Over-ripeness Over-ripeness

OvopathyOvopathy(PrOO Concept) (PrOO Concept)

MTHFR gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy ,Piet H et al;

Jr of Experimental & Clinical Assisted Reproduction 2008, 5:5

Page 41: Baiju dhea 15.11.12

Page 41

Page 42: Baiju dhea 15.11.12

Page 42

Page 43: Baiju dhea 15.11.12

Page 43

•Delayed child bearing is the most important precipitating factor which

increases the number of poor responders

•Physiological rise in itnra-ovarian testosterone can be achieved with DHEA

supplementation

•Improved Ovarian Response to treatment can be expected with 3-4

months of DHEA in DOR

•Robust evidences in terms of increasing LBR with DHEA treatment is still lacking

•“ABSENCE OF EVIDENCE IS NOT EVIDENCE OF ABSENCE”

•Role of CoQ10 & Folic acid in improving oocyte quality has to explored further

Page 44: Baiju dhea 15.11.12

Page 44